OKYO Pharma Limited Adjustments For Income Tax Expense
OKYO Pharma Limited (OKYO) reported Adjustments For Income Tax Expense of -$3.26 million for the 12-month period ending 2025-03-31, per its 20-F filed 2025-07-18.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForIncomeTaxExpense · last filed 2025-07-18
| Period end | Adjustments For Income Tax Expense 12 month |
|---|---|
| 2025-03-31 | -$3.26M 20-F · filed 2025-07-18 |
| 2024-03-31 | $22.42K 20-F · filed 2025-07-18 |
| 2023-03-31 | -$12.20K 20-F · filed 2025-07-18 |
| 2022-03-31 | -$786.52K 20-F · filed 2024-08-13 |